Farida Ahangari
Overview
Explore the profile of Farida Ahangari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
2087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurbanov D, Ahangari F, Adams T, De Man R, Tang J, Carlon M, et al.
Am J Physiol Lung Cell Mol Physiol
. 2025 Feb;
328(3):L456-L462.
PMID: 39970931
In this research, we delve into the association between epigenetic aging and idiopathic pulmonary fibrosis (IPF), a debilitating lung disease that progresses over time. Utilizing the Illumina MethylationEPIC array, we...
2.
Yuan Y, Sharma L, Tang W, Yoon Y, Kirk S, Raredon M, et al.
bioRxiv
. 2025 Jan;
PMID: 39763730
Disorders in pulmonary vascular integrity are a prominent feature in many lung diseases. Paracrine signaling is highly enriched in the lung and plays a crucial role in regulating vascular homeostasis....
3.
Trujillo G, Regueiro-Ren A, Liu C, Hu B, Sun Y, Ahangari F, et al.
Am J Respir Crit Care Med
. 2024 Aug;
PMID: 39189851
Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease for which current treatment options only slow clinical progression. Previously, we identified a subset of patients with IPF with an...
4.
Zhao A, Unterman A, Abu Hussein N, Sharma P, Nikola F, Flint J, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(10):1252-1266.
PMID: 38924775
Fibrotic hypersensitivity pneumonitis (FHP) is a debilitating interstitial lung disease driven by incompletely understood immune mechanisms. To elucidate immune aberrations in FHP in single-cell resolution. Single-cell 5' RNA sequencing was...
5.
Mannes P, Adams T, Farsijani S, Barnes C, Latoche J, Day K, et al.
Sci Adv
. 2024 Jun;
10(25):eadm9817.
PMID: 38896611
Precision management of fibrotic lung diseases is challenging due to their diverse clinical trajectories and lack of reliable biomarkers for risk stratification and therapeutic monitoring. Here, we validated the accuracy...
6.
Unterman A, Zhao A, Neumark N, Schupp J, Ahangari F, Cosme Jr C, et al.
Am J Respir Crit Care Med
. 2024 May;
210(4):484-496.
PMID: 38717443
Changes in peripheral blood cell populations have been observed, but not detailed, at single-cell resolution in idiopathic pulmonary fibrosis (IPF). We sought to provide an atlas of the changes in...
7.
Feng J, Liu Y, Kim J, Ahangari F, Kaminski N, Bain W, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Feb;
326(5):L551-L561.
PMID: 38375579
Excessive or persistent inflammation may have detrimental effects on lung structure and function. Currently, our understanding of conserved host mechanisms that control the inflammatory response remains incompletely understood. In this...
8.
Zheng Y, Schupp J, Adams T, Clair G, Justet A, Ahangari F, et al.
Res Sq
. 2024 Jan;
PMID: 38196613
Human diseases are characterized by intricate cellular dynamics. Single-cell sequencing provides critical insights, yet a persistent gap remains in computational tools for detailed disease progression analysis and targeted in-silico drug...
9.
Zhao A, Unterman A, Abu Hussein N, Sharma P, Flint J, Yan X, et al.
bioRxiv
. 2023 Oct;
PMID: 37786685
Rationale And Objectives: The extent and commonality of peripheral blood immune aberrations in fibrotic interstitial lung diseases are not well characterized. In this study, we aimed to identify common and...
10.
Unterman A, Zhao A, Neumark N, Schupp J, Ahangari F, Cosme Jr C, et al.
medRxiv
. 2023 May;
PMID: 37163015
Rationale: Changes in peripheral blood cell populations have been observed but not detailed at single-cell resolution in idiopathic pulmonary fibrosis (IPF). Objectives: To provide an atlas of the changes in...